Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Understanding Subjective Outcome Measures In HAP Studies
Understanding how a participant "feels" is essential for drug safety. Explore how subjective measures and specialized training provide the data needed to evaluate human abuse potential.
9 Strategies To Increase Enrollment In Clinical Trials
An effective participant enrollment strategy is crucial to ensuring clinical trial success and avoiding missed deadlines, increased costs, and flawed trial outcomes.
Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
All You Need To Know About 505(b)(2), But Were Afraid To Ask
Join us to explore the 505(b)(2) pathway. Learn how to bring improved drugs to market faster, reduce costs, and add value with this streamlined regulatory approach.

5 Common Misconceptions About Mobile Visits In Clinical Trials
10/11/2024

In this article, we address five key misconceptions about mobile research services, including concerns about inconsistent nurse assignments, privacy risks, and limited applications for complex protocols.
Why Early Phase Speed Depends On Oncology Expertise
5/1/2026

Early phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.
De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital
9/3/2025

For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.
EDC Powers End-To-End Data Management In Pharma-Sponsored Trials
9/4/2025

As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
Delivering A Registrational GI Trial Through Ongoing Protocol Shifts
10/17/2025

A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.

Mastering Multi-Channel, Multi-Vendor Clinical Trial Recruitment

See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
Unify Workflows And Accelerate Execution From Protocol To Submission

Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
Driving Efficiency And ROI In Clinical Trials

Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
The North American Advantage

With more than 80% of Avance Clinical’s biotech clients located in North America, the region has played a significant role in the almost three decades of the company’s growth.
Think Bold. Think Scientific. Think Veristat.

Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.